Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab

Giovanni Rossi; Matteo Bauckneht; Carlo Genova; Erika Rijavec; Federica Biello; Simone Mennella; Maria Giovanna Dal Bello; Giuseppe Cittadini; Paolo Bruzzi; Roberta Piva; Valentina Ceriani; Gianmario Sambuceti; Egesta Lopci; Silvia Morbelli; Francesco Grossi

doi:10.2967/jnumed.119.233056

OtherClinical Investigations (Human)

Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab

Giovanni Rossi, Matteo Bauckneht, Carlo Genova, Erika Rijavec, Federica Biello, Simone Mennella, Maria Giovanna Dal Bello, Giuseppe Cittadini, Paolo Bruzzi, Roberta Piva, Valentina Ceriani, Gianmario Sambuceti, Egesta Lopci, Silvia Morbelli and Francesco Grossi

Journal of Nuclear Medicine December 2019, jnumed.119.233056; DOI: https://doi.org/10.2967/jnumed.119.233056

Giovanni Rossi

1 Lung Cancer Unit, IRCCS Policlinico San Martino, Genoa, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matteo Bauckneht

2 Nuclear Medicine Unit, IRCCS Policlinico San Martino, Genoa, Italy, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Carlo Genova

1 Lung Cancer Unit, IRCCS Policlinico San Martino, Genoa, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Erika Rijavec

3 Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Federica Biello

1 Lung Cancer Unit, IRCCS Policlinico San Martino, Genoa, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Simone Mennella

4 Radiology Unit, IRCCS Policlinico San Martino, Genoa, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maria Giovanna Dal Bello

1 Lung Cancer Unit, IRCCS Policlinico San Martino, Genoa, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Giuseppe Cittadini

4 Radiology Unit, IRCCS Policlinico San Martino, Genoa, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Paolo Bruzzi

5 Epidemiology Unit, IRCCS Policlinico San Martino, Genoa, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Roberta Piva

2 Nuclear Medicine Unit, IRCCS Policlinico San Martino, Genoa, Italy, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Valentina Ceriani

2 Nuclear Medicine Unit, IRCCS Policlinico San Martino, Genoa, Italy, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gianmario Sambuceti

2 Nuclear Medicine Unit, IRCCS Policlinico San Martino, Genoa, Italy, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Egesta Lopci

6 Nuclear Medicine Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Silvia Morbelli

2 Nuclear Medicine Unit, IRCCS Policlinico San Martino, Genoa, Italy, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Francesco Grossi

3 Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 6

June 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab

Journal of Nuclear Medicine Dec 2019, jnumed.119.233056; DOI: 10.2967/jnumed.119.233056

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab

Journal of Nuclear Medicine Dec 2019, jnumed.119.233056; DOI: 10.2967/jnumed.119.233056

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Predictive value of 3'-deoxy-3'-18F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer
Response Evaluation and Survival Prediction After PD-1 Immunotherapy in Patients with Non-Small Cell Lung Cancer: Comparison of Assessment Methods

Google Scholar

Clinical Investigations (Human)

The added value of ¹⁸F-FDG PET/CT compared to ⁶⁸Ga-PSMA PET/CT in patients with castration-resistant prostate cancer

Show more Clinical Investigations (Human)

Clinical (Oncology: Lung)

First-in-Humans Evaluation of a PD-L1–Binding Peptide PET Radiotracer in Non–Small Cell Lung Cancer Patients
Efficacy and Safety of ¹⁷⁷Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study

Show more Clinical (Oncology: Lung)

Keywords

Oncology: Lung
PET/CT
Other
computed tomography
NSCLC
Positron Emission Tomography
checkpoint inhibitors

Main menu

User menu

Search

Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Clinical Investigations (Human)

Clinical (Oncology: Lung)

Similar Articles

Keywords